Home
EVERSANA

EVERSANA Market Share Analysis for May 2026

a fully integrated, life sciences commercial services company -designed to solve pricing, access, reimbursement, adherence and product delivery challenges

Health > Biotechnology and Pharmaceuticals

Domaineversana.com

Year Founded2014

Employees5001 - 10000

Annual Revenue> $1B

EVERSANA

EVERSANA (including company regionals)

eversana.com

See more website traffic and engagement information

EVERSANA Revenue up to May 2026 is > 1B

revenue generated by EVERSANA top domains

EVERSANA top domains revenue over 3 years

Revenue for EVERSANA top domains

eversana.com> 1B

See more with Sales Intelligence

Total visits to EVERSANA's top domains

Understand EVERSANA market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

eversana.com47.5K

See more with Sales Intelligence

Avg. visit duration in EVERSANA's top domains

Analyze EVERSANA engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

eversana.com00:02:01

See more with Sales Intelligence

Avg. pageviews on EVERSANA's top domains

See how EVERSANA keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

eversana.com3.52

See more with Sales Intelligence

EVERSANA top competitors by domain

Top similar sites in May 2026, ranked by their affinity

mmitnetwork.comCompany NameMMITEmployees201 - 500HQUnited States, Pennsylvania, YardleyAnnual revenue$10M - $15MTotal visits35.3KHealth > Pharmacy

Top technologies used by EVERSANA

These are the website technologies, by industry, used by EVERSANA top domains

Advertising (6)

DoubleClick

Widget (6)

Twemoji

Conversion & Analytics (4)

Google Analytics

Email Services (4)

Microsoft Exchange Online

More Technologies

12

See all

News & Signals from EVERSANA

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEVERSANA Life Sciences LLC attends event 2026 ASCO Annual Meeting.Following a week of groundbreaking data, emerging treatment paradigms and shifting conversations around access at the 2026 ASCO Annual Meeting, Pharmaceutical Executive sat down with Anne Marie Robertson, EVP of EVERSANA Oncology Commercialization(TM), to reflect on her experiences at the largest oncology event in the North America and trends in the industry.

NewsCandel Therapeutics, Inc. partnered with EVERSANA Life Sciences LLC on Apr 29th '26.Candel Therapeutics, a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to help patients with cancer, today announced that it entered into a product commercialization agreement with EVERSANA, a provider of global commercialization services to the life sciences industry, to support the potential U.S. commercial launch of aglatimagene besadenovec (aglatimagene or CAN-2409) for the treatment of intermediate- to high-risk, localized prostate cancer.

NewsXcovery Holdings, Inc. partnered with EVERSANA Life Sciences LLC on Apr 27th '26.MIAMI and CHICAGO, April 27, 2026 /PRNewswire/ - Xcovery Holdings, Inc., (Xcovery) an evidence-based, innovation-driven pharmaceutical company, today announced an agreement with EVERSANA(R), a leading provider of commercialization services to the global life sciences industry, to support and expand the U.S. commercial launch of ENSACOVE(TM)(ensartinib), the company's novel therapy for adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC).